Azilsartan Medoxomil Film-Coated Tablets (40 mg / 80 mg)
Healthy Inc is a specialized global supplier and exporter of advanced cardiology, nephrology, and targeted cardiovascular therapeutics. We provide ultra-high-purity, kinetically optimized Azilsartan Medoxomil Tablets, manufactured in WHO–GMP certified, high-precision oral solid dosage facilities. This “Next-Generation ARB” is a premium strategic export to cardiology hospitals, hypertension centers, and government health ministries, serving as the globally mandated intervention for Essential Hypertension and 24-hour ambulatory blood pressure management.
Product Overview
This formulation operates as a high-affinity “Vessel Relaxant.” Azilsartan is a prodrug (Medoxomil ester) that is rapidly converted to its active form, providing a more potent and sustained blockade of the receptors that cause blood vessels to tighten.
Mechanism 1 (Selective AT1 Blockade): Azilsartan selectively binds to the Angiotensin II Type 1 ($AT_1$) Receptors with much higher affinity and slower dissociation than older ARBs. By blocking these receptors, it prevents Angiotensin II from causing vasoconstriction (tightening of the vessels).
Mechanism 2 (Sustained 24-Hour Control): Due to its unique chemical binding, Azilsartan provides superior 24-hour blood pressure reduction, particularly during the early morning hours when the risk of stroke and heart attack is highest.
Mechanism 3 (Aldosterone Suppression): By blocking the $AT_1$ receptor, it also reduces the secretion of Aldosterone, leading to decreased sodium and water retention by the kidneys, further lowering blood pressure.
Product Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-Alu blister strips to ensure the stability of the Medoxomil ester.
| Active Ingredient | Strength | Primary Clinical Function |
| Azilsartan Medoxomil Potassium | 40 mg | The Standard Initiation Unit: The primary starting dose for most adult patients with hypertension. |
| Azilsartan Medoxomil Potassium | 80 mg | The High-Potency Payload: For patients requiring additional blood pressure lowering beyond the 40 mg dose. |
| Excipients | Proprietary Matrix | Hydrolysis-Stable System: Engineered to prevent premature breakdown of the prodrug before it reaches the gastrointestinal tract. |
Technical & Logistics Specifications
HS Code: 3004.90.99 (Medicaments containing other active substances – Cardiovascular)
CAS Number: 863031-21-4 (Azilsartan Medoxomil Potassium)
Dosage Form: Film-Coated Tablet
Packaging: Alu-Alu Blisters (MANDATORY). Azilsartan Medoxomil is highly sensitive to moisture; our moisture-lock packaging ensures 24-month stability in Zone IVb tropical climates.
Manufacturing Authority & Compliance
Medoxomil Stability Mastery: Our manufacturing process focuses on absolute environmental control, ensuring the Medoxomil ester remains intact and free from degradation, providing 100% bioequivalence to the innovator brand (Edarbi).
Impurity Profiling: We utilize advanced HPLC to monitor for nitrosamine-free synthesis, meeting the latest global safety standards for ARB class medications.
Primary Indications
Cardiology: Treatment of Essential Hypertension (High Blood Pressure) in adults.
Nephrology: Management of hypertension in patients with early-stage chronic kidney disease (under specialist supervision).
Dosage & Administration
Standard Adult Dosing: 40 mg once daily, with or without food. The dose may be increased to 80 mg if blood pressure is not adequately controlled.
The “Morning Pulse” Advantage: Taking the tablet in the morning ensures maximum protection during the peak physiological blood pressure surge.
Safety Warning: Fetal Toxicity. Strictly contraindicated in pregnancy. Monitor for Hyperkalemia (high potassium) and renal function, especially in patients taking diuretics or those with kidney impairment.
Global Export & Contract Manufacturing
Healthy Inc is a premier Cardiovascular Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for next-generation ARBs. Whether you are a Cardiology Specialist Network in Africa or a B2B Pharma Marketplace partner in Southeast Asia, we ensure secure, WHO-GMP compliant delivery.